These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 38482522

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y, Zhou L, Shen Z, Ma Q, Zhao Y, Sun Y, Cao J.
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cancer-Responsive Multifunctional Nanoplatform Based on Peptide Self-Assembly for Highly Efficient Combined Cancer Therapy by Alleviating Hypoxia and Improving the Immunosuppressive Microenvironment.
    Wu J, Liu Y, Cao M, Zheng N, Ma H, Ye X, Yang N, Liu Z, Liao W, Sun L.
    ACS Appl Mater Interfaces; 2023 Feb 01; 15(4):5667-5678. PubMed ID: 36651290
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y, Yang X, Li H, Li C, Ding H, Zhang M, Guo Y, Sun M.
    Colloids Surf B Biointerfaces; 2019 Jan 01; 173():564-570. PubMed ID: 30347383
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Near-infrared photoactivatable three-in-one nanoagents to aggravate hypoxia and enable amplified photo-chemotherapy.
    Yu N, Zhou J, Xu H, Wang F, Wang X, Tang L, Li J, Wang X, Lu X.
    Biomater Adv; 2024 Oct 01; 163():213962. PubMed ID: 39032435
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
    Yu H, Li Y, Zhang Z, Ren J, Zhang L, Xu Z, Kang Y, Xue P.
    Acta Biomater; 2022 Jan 15; 138():545-560. PubMed ID: 34775125
    [Abstract] [Full Text] [Related]

  • 33. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
    Zhang K, Zhang Y, Meng X, Lu H, Chang H, Dong H, Zhang X.
    Biomaterials; 2018 Dec 15; 185():301-309. PubMed ID: 30265899
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L, Fu J, Ye J, Liu L, Sun Z, Wang H, Tan S, Zhen M, Wang C, Bai C.
    Adv Mater; 2024 Jun 15; 36(23):e2310875. PubMed ID: 38450765
    [Abstract] [Full Text] [Related]

  • 39. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy.
    Li SY, Cheng H, Qiu WX, Zhang L, Wan SS, Zeng JY, Zhang XZ.
    Biomaterials; 2017 Oct 15; 142():149-161. PubMed ID: 28735175
    [Abstract] [Full Text] [Related]

  • 40. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
    Zhu T, Shi L, Yu C, Dong Y, Qiu F, Shen L, Qian Q, Zhou G, Zhu X.
    Theranostics; 2019 Oct 15; 9(11):3293-3307. PubMed ID: 31244955
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.